Nev. Admin. Code § 441A.200

Current through November 8, 2024
Section 441A.200 - List of adopted recommendations, guidelines and publications; review of revision or amendment of adopted recommendation, guideline or publication
1. Except as otherwise provided in subsection 2, the following recommendations, guidelines and publications are adopted by reference:
(a) The standard precautions to prevent transmission of disease by contact with blood or other body fluids as recommended by the Centers for Disease Control and Prevention in "Perspectives in Disease Prevention and Health Promotion Update: Universal Precautions for Prevention of Transmission of Human Immunodeficiency Virus, Hepatitis B Virus, and Other Bloodborne Pathogens in Health-Care Settings," Morbidity and Mortality Weekly Report [37(24):377-388, June 24, 1988], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division.
(b) The Centers for Disease Control and Prevention's 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings, published by the United States Department of Health and Human Services and available at no cost on the Internet at https://www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines-H.pdf, or, if that Internet website ceases to exist, from the Division.
(c) The recommended guidelines for the investigation, prevention, suppression and control of communicable disease set forth by the Centers for Disease Control and Prevention in:
(1) "General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices," Morbidity and Mortality Weekly Report [55(RR15):1- 48, December 1, 2006], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division; and
(2)Manual for the Surveillance of Vaccine-Preventable Diseases, published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/vaccines/pubs/surv-manual/index.html, or, if that Internet website ceases to exist, from the Division.
(d) The recommended guidelines for the investigation, prevention, suppression and control of communicable diseases contained in Control of Communicable Diseases Manual, 21st edition, published by the American Public Health Association and available for the price of $59.50 for members and $85.00 for nonmembers from the American Public Health Association, 800 I Street, N.W., Washington, D.C. 20001-3710, or at the Internet address http://www.apha.org.
(e) The recommended guidelines for the investigation, prevention, suppression and control of communicable diseases contained in Red Book: 2021 Report of the Committee on Infectious Diseases, 32nd edition, published by the American Academy of Pediatrics and available for the price of $119.95 for members and $149.95 for nonmembers from the American Academy of Pediatrics, 345 Park Boulevard, Itasca, Illinois 60143, or at the Internet address https://shop.aap.org.
(f) The recommendations for the testing, treatment, prevention, suppression and control of chancroid, Chlamydia trachomatis, gonococcal infection, granuloma inguinale, lymphogranuloma venereum, infectious syphilis and human immunodeficiency virus as are specified in "Sexually Transmitted Infections Treatment Guidelines, 2021," Morbidity and Mortality Weekly Report [70(4):1-187, July 23, 2021], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division.
(g) The recommendations for the counseling of and effective treatment for a person having active tuberculosis or tuberculosis infection as set forth in:
(1) Controlling Tuberculosis in the United States: Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America," Morbidity and Mortality Weekly Report [54(RR12):1-81, November 4, 2005], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division;
(2) "Treatment of Tuberculosis," Morbidity and Mortality Weekly Report [52(RR11):1-77, June 20, 2003], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division;
(3) "Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection," Morbidity and Mortality Weekly Report [49(RR06):1-54, June 9, 2000], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division;
(4) The recommendations of the Centers for Disease Control and Prevention for preventing and controlling tuberculosis in correctional and detention facilities set forth in "Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC," Morbidity and Mortality Weekly Report [55(RR09):1-44, July 7, 2006], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division; and
(5) Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC," Morbidity and Mortality Weekly Report [54(RR15):1-37, December 16, 2005], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division.
(h) The recommendations of the Centers for Disease Control and Prevention for preventing the transmission of tuberculosis in facilities providing health care set forth in "Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005," Morbidity and Mortality Weekly Report [54(RR17):1-141, December 30, 2005], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division.
(i) "Case Definitions for Infectious Conditions Under Public Health Surveillance," Morbidity and Mortality Weekly Report [46(RR10):1-55, May 2, 1997], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division.
(j) "Recommended Antimicrobial Agents for Treatment and Postexposure Prophylaxis of Pertussis: 2005 CDC Guidelines," Morbidity and Mortality Weekly Report [54(RR14):1-16, December 9, 2005], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division.
(k) "Updated Recommendations for Isolation of Persons with Mumps," Morbidity and Mortality Weekly Report [57(40):1103-1105, October 10, 2008], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division.
(l) "Recommendations for Partner Services Programs for HIV Infection, Syphilis, Gonorrhea, and Chlamydial Infection," Morbidity and Mortality Weekly Report [57(RR09):1-83, November 7, 2008], published by the United States Department of Health and Human Services and available at no cost on the Internet at http://www.cdc.gov/mmwr, or, if that Internet website ceases to exist, from the Division.
(m) "Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE)," published by the United States Department of Health and Human Services and available at no cost from the Centers for Disease Control and Prevention on the Internet at https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf, or, if that Internet website ceases to exist, from the Division.
(n) "Interim Guidance for a Public Health Response to Contain Novel or Targeted Multidrug-resistant Organisms (MDROs)," published by the United States Department of Health and Human Services and available at no cost from the Centers for Disease Control and Prevention on the Internet at https://www.cdc.gov/hai/pdfs/containment/Health-Response-Contain-MDRO-H.pdf, or, if that Internet website ceases to exist, from the Division.
(o) The guidelines for the prevention, postexposure management and control of rabies as specified in the "Compendium of Animal Rabies Prevention and Control, 2016," published by the National Association of State Public Health Veterinarians and available at no cost on the Internet at http://nasphv.org/documentsCompendiaRabies.html, or, if that Internet website ceases to exist, from the Division.
(p) "Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) 2018 Case Definition," published by the United States Department of Health and Human Services and available at no cost on the Internet at https://ndc.services.cdc.gov/case-definitions/carbapenemase-producing-carbapenem-resistant-enterobacteriaceae-2018/, or, if that Internet website ceases to exist, from the Division.
(q) The recommendations for offering culturally and linguistically appropriate services set forth in "National Standards for Culturally and Linguistically Appropriate Services (CLAS) in Health and Health Care," published by the United States Department of Health and Human Services and available at no cost on the Internet at https://thinkculturalhealth.hhs.gov/clas, or, if that Internet website ceases to exist, from the Division.
(r) "Human Immunodeficiency Virus (HIV) Infection: Screening," published by the United States Preventive Services Task Force and available at no cost on the Internet at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening, or, if that Internet website ceases to exist, from the Division.
(s) "Syphilis Infection in Nonpregnant Adolescents and Adults: Screening," published by the United States Preventive Services Task Force and available at no cost on the Internet at https://uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-nonpregnant-adults-adolescents-screening, or, if that Internet website ceases to exist, from the Division.
(t) "Chlamydia and Gonorrhea: Screening," published by the United States Preventive Services Task Force and available at no cost on the Internet at https://uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening, or, if that Internet website ceases to exist, from the Division.
2. Except as otherwise provided in this subsection, the most current version of a recommendation, guideline or publication adopted by reference pursuant to subsection 1 which is published will be deemed to be adopted by reference. If both the state and local health authorities determine that an update of or revision to a recommendation, guideline or publication described in subsection 1 is not appropriate for use in the State of Nevada, the Chief Medical Officer will present this determination to the Board and the update or revision, as applicable, will not be adopted. If the agency or other entity that publishes a recommendation, guideline or publication described in subsection 1 ceases to publish the recommendation, guideline or publication:
(a) The last version of the recommendation, guideline or publication that was published before the agency or entity ceased to publish the recommendation, guideline or publication shall be deemed to be the current version; and
(b) The recommendation, guideline or publication will be made available on an Internet website maintained by the Division.

Nev. Admin. Code § 441A.200

Added to NAC by Bd. of Health, eff. 1-24-92; A by R047-99, 9-27-99; R084-06, 7-14-2006; R087-08, 1-13-2011; A by R121-14, eff. 10/27/2015; A by R187-18A, eff. 6/12/2019; A by R148-22A, eff. 7/26/2023; A by R002-22A, eff. 9/18/2023

NRS 439.200, 441A.120, 441A.315